Advised a Korean company on a global merger filing in relation to its acquisition of a manufacturer of the main material for rechargeable batteries.
Advised a global merger filing case in relation to the establishment of a joint venture for the automotive battery industry.
Assisted a multinational pharmaceutical company in a merger filing case.
Advised a Korean company on merger filing in relation to its acquisition of a mobility startup.
Advised a Korean company in the shipbuilding sector on a global merger filing case, coordinating filings in multiple jurisdictions.
Advised a Korean semiconductor company on a merger filing in relation to the acquisition of an overseas semiconductor business.
Provide advice to a domestic pharmaceutical company on a merger filing in relation to its acquisition of a domestic radioactive drug business
Asissted a global digital security company in a merger filing case.

Represented a global medical device company in its investigation under the Act on Fair Agency Transactions in Distributorship.
Represented a domestic pharmaceutical company in its investigation of unfair customer solicitation.
Advised on internal transaction compliance for the Korean conglomerate.
Represented a Korean company in its investigation regarding the provision of undue support.
Represented a global household product company in a potential unfair labeling/advertising case.
Represented a global bank in its investigation of unfair collusive acts.
Represented the investigation of unfair cartel behavior related to cable tender.
Represented an oil & chemical product company in the investigation of unfair collusive acts.
Provided advice on unfair trade practices of various pharmaceutical/medical device/cosmetics/food companies.

Awards

• Stand-out Lawyer - Independently Rated Lawyers (Thomson Reuters, 2024-2025)
• Leading Lawyer, Asialaw Leading Lawyers: Competition/Antitrust (Delinian, 2022-2024)
• Leading Lawyer, Asialaw Leading Lawyers: Pharmaceuticals and life sciences (Delinian, 2022-2024)
• Rising Stars Awards Asia-Pacific 2022: Life sciences (Euromoney, 2022)

Publications/Activities

• The Asia-Pacific Antitrust Review 2018 (Co-author, Law Business Research, 2018)